Intrinsic Value of S&P & Nasdaq Contact Us

Evolus, Inc. EOLS NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+237.8%

Evolus, Inc. (EOLS) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 11 recommend buying, 2 recommend holding, and 0 recommend selling.

The analyst consensus price target for EOLS is $15.00, representing a +237.8% upside from the current price of $4.44. Price targets range from a low of $13.00 to a high of $17.00.

Analyst Consensus — EOLS

Buy
Strong Buy
0
Buy
11
Hold
2
Sell
0
Strong Sell
0
13 analysts
Price Targets
Consensus$15.00
High$17.00
Low$13.00
Median$15.00
Last Month Avg-
Last Quarter Avg$15.00
Last Year Avg$16.00
All-Time Count8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message